newmedsupplies.com: DMEMEDS shared post via Reuters: GSK in $350 million deal to develop cancer drugs with UK biotech firm: FT

Sunday, June 1, 2014

DMEMEDS shared post via Reuters: GSK in $350 million deal to develop cancer drugs with UK biotech firm: FT

(Reuters) - GlaxoSmithKline Plc has agreed a deal worth more than $350 million with UK biotech company Adaptimmune to develop cancer drugs, the Financial Times reported on Monday. [Category: healthNews] http://feeds.reuters.com/~r/reuters/healthNews/~3/Mw6ZuGWFFkk/story01.htm

Read More

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)